Search


The CEO of the London-based life science investment firm Syncona shares his thoughts on the sector
Chris Hollowood gives his take on biotech, the UK, portfolio companies iOnctura, Yellowstone Biosciences, and Spur Therapeutics...
Jun 26, 2024
Also look for unique social pages for BiotechTV U.
Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.
​
​Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.